These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study. Banyai S, Jenelten R, Wagner S, Allmann J, Banyai M, Koppensteiner R. Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272 [Abstract] [Full Text] [Related]
25. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone. Rothwell DL, Bremner DA, Taylor KM. N Z Med J; 1983 May 25; 96(732):392-4. PubMed ID: 6302612 [Abstract] [Full Text] [Related]
29. Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections. Boccazzi A, Tonelli P, Bellosta C, Careddu P. Diagn Microbiol Infect Dis; 1998 Dec 25; 32(4):265-72. PubMed ID: 9934543 [Abstract] [Full Text] [Related]
30. Cefodizime in clinical use: a review of the clinical trial reports. Grassi GG. J Antimicrob Chemother; 1990 Nov 25; 26 Suppl C():117-25. PubMed ID: 2074246 [Abstract] [Full Text] [Related]
32. Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients. Morales JO, Snead H. Am J Med; 1994 Aug 15; 97(2A):28-33. PubMed ID: 8059798 [Abstract] [Full Text] [Related]
33. Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics. Kafetzis DA, Brater DC, Kapiki AN, Papas CV, Dellagrammaticas H, Papadatos CJ. J Pediatr; 1982 Mar 15; 100(3):483-9. PubMed ID: 6278118 [Abstract] [Full Text] [Related]
34. Cefotaxime therapy of serious bacterial infection in adults. Mullaney DT, John JF. Antimicrob Agents Chemother; 1982 Mar 15; 21(3):421-5. PubMed ID: 6285810 [Abstract] [Full Text] [Related]
35. Treatment of bone and joint infections utilizing a third-generation cephalosporin with an outpatient drug delivery device. HIAT Study Group. Mauceri AA. Am J Med; 1994 Aug 15; 97(2A):14-22. PubMed ID: 8059796 [Abstract] [Full Text] [Related]
36. Workshop on five years of clinical experience with cefotaxime (with special reference to gram-positive infections). February 21 and 22, 1985, West Berlin. Infection; 1985 Aug 15; 13 Suppl 1():S1-162. PubMed ID: 3902651 [No Abstract] [Full Text] [Related]
37. Treatment of serious infections with cefotaxime utilizing an outpatient drug delivery device: global analysis of a large-scale, multicenter trial. HIAT Study Group. Poretz DM. Am J Med; 1994 Aug 15; 97(2A):34-42. PubMed ID: 8059800 [Abstract] [Full Text] [Related]
38. Efficacy of a low dose of cefotaxime in serious chest infections. Cade JF, Presneill J, Keighley C, Sinickas V. Chest; 1992 May 15; 101(5):1393-8. PubMed ID: 1582303 [Abstract] [Full Text] [Related]
39. Cefotaxime in the treatment of infections of the skin and skin structure. McCloskey RV, Goren R, Bissett D, Bentley J, Tutlane V. Rev Infect Dis; 1982 May 15; 4 Suppl():S444-7. PubMed ID: 6294797 [Abstract] [Full Text] [Related]
40. Management of rhinoscleroma, a new concept. Fatthi A, Nada G, el-Altreby MN. Chemioterapia; 1987 Jun 15; 6(2 Suppl):556-7. PubMed ID: 3509499 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]